Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.5771
-0.0401 (-6.50%)
At close: May 30, 2025, 4:00 PM
0.6100
+0.0329 (5.70%)
After-hours: May 30, 2025, 7:19 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $51.77 million as of May 30, 2025. Its market cap has decreased by -59.63% in one year.
Market Cap
51.77M
Enterprise Value
-37.39M
1-Year Change
-59.63%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $51.77M, an increase of 1.45%. That is a compound annual growth rate of 0.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 51.77M | -45.04% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.03B |
| Johnson & Johnson | 368.61B |
| AbbVie | 327.42B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 268.79B |
| Abbott Laboratories | 230.84B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |